WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2019

May 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2019-04-30

Reporting Person: Malone Daniel (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-30	Common Stock	M	4458.00	$21.34	Acquired	33478.3934	Direct
2019-04-30	Common Stock	S	4458.00	$123.0321	Disposed	29020.3934	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-30	Stock Options (Right to Buy)	$21.34	M	4458.00	Disposed	2020-03-22	Common Stock (4458.00)	Direct

Footnotes

F1: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $123.00 to $123.07, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.